| 901 | LOUGHLIN, CATHERINEDURHAM, NC · 27701 | VICE PRESIDENT, US SPECIALTY AND ONCOL · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-10-06 | $15 | Primary (P) | Filing 1926331FEC filing ↗ |
| 902 | NIJINSKY, SONYA ALEXANDRA MOIRAPHILADELPHIA, PA · 19112 | INTERNAL QUALITY AUDIT · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-10-06 | $15 | Primary (P) | Filing 1926331FEC filing ↗ |
| 903 | CRUZ, CHRISTIAN OMARWASHINGTON, DC · 20004 | PUBLIC POLICY · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-10-06 | $15 | Primary (P) | Filing 1926331FEC filing ↗ |
| 904 | BERGEY, AMANDA SCHROEDERPHILADELPHIA, PA · 19112 | PRODUCT STRATEGY & DEVELOPMENT · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-10-06 | $15 | Primary (P) | Filing 1926331FEC filing ↗ |
| 905 | CARDELLI, PAULDURHAM, NC · 27709 | RX ACCOUNT MANAGEMENT ONCOLOGY · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-10-06 | $15 | Primary (P) | Filing 1926331FEC filing ↗ |
| 906 | NEILSON, NICHOLAS JAMESDURHAM, NC · 27709 | PRICING/REIMBURSEMENT - NICHOLAS NEILS · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-10-06 | $15 | Primary (P) | Filing 1926331FEC filing ↗ |
| 907 | ANDERSON, CHARLES ALLENDURHAM, NC · 27709 | RX ACCOUNT MANAGEMENT RESP BIOLOGICS · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-10-06 | $15 | Primary (P) | Filing 1926331FEC filing ↗ |
| 908 | BROWN, BRENT WILLIAM GEORGEDURHAM, NC · 27709 | SALES FORCE EFFECTIVENESS (ONCOLOGY) · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-10-06 | $15 | Primary (P) | Filing 1926331FEC filing ↗ |
| 909 | GALLAGHER, RUSTINDURHAM, NC · 27709 | VACCINE STRATEGIC ACCT LEAD · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-10-06 | $15 | Primary (P) | Filing 1926331FEC filing ↗ |
| 910 | JOHNSON, KATHLEEN CASEYDURHAM, NC · 27709 | REGIONAL ACCOUNT EXECUTIVE · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-10-06 | $15 | Primary (P) | Filing 1926331FEC filing ↗ |
| 911 | GALLOWAY, BIJALDURHAM, NC · 27701 | SENIOR GLOBAL MARKETING DIRECTOR · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-10-06 | $15 | Primary (P) | Filing 1926331FEC filing ↗ |
| 912 | FURUYA, CHRIS A.DURHAM, NC · 27709 | RX ACCOUNT MANAGEMENT RESP BIOLOGICS · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-10-06 | $15 | Primary (P) | Filing 1926331FEC filing ↗ |
| 913 | HASELWANDER, MARK ADURHAM, NC · 27709 | VACCINE ACCT EXECUTIVE · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-10-06 | $15 | Primary (P) | Filing 1926331FEC filing ↗ |
| 914 | PAPANICKOLAS, YVONNE MARIEDURHAM, NC · 27709 | SR SALES SPEC, PHARMA · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-10-06 | $15 | Primary (P) | Filing 1926331FEC filing ↗ |
| 915 | SHELBY, URSULA DDURHAM, NC · 27709 | ACCT SPEC, VACCINES · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-10-06 | $15 | Primary (P) | Filing 1926331FEC filing ↗ |
| 916 | BARNETT, BROOKE NICOLEDURHAM, NC · 27709 | SALES SPEC PHARMA · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-10-06 | $15 | Primary (P) | Filing 1926331FEC filing ↗ |
| 917 | SUMMERS, DENA MPHILADELPHIA, PA · 19112 | HEALTH OUTCOMES · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-10-06 | $15 | Primary (P) | Filing 1926331FEC filing ↗ |
| 918 | MOLLISON, SCOT RONALDDURHAM, NC · 27709 | RX SALES PRIMARY CARE · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-10-06 | $15 | Primary (P) | Filing 1926331FEC filing ↗ |
| 919 | WEISSER, STEVEN MCOLLEGEVILLE, PA · 19426 | SCIENTIFIC PROJECT LEADERSHIP · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-10-06 | $15 | Primary (P) | Filing 1926331FEC filing ↗ |
| 920 | DEKREY, STEVEN MDURHAM, NC · 27709 | SR SALES SPEC, PHARMA · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-10-06 | $15 | Primary (P) | Filing 1926331FEC filing ↗ |